| Name | L-Tryptophanamide, L-tryptophyl-L-arginyl-L-tryptophyl-L-tryptophyl-L-tryptophyl |
|---|---|
| Synonyms | NPEC-caged-noradrenalin |
| Description | WRW4, a specific formyl peptide receptor-like 1 (FPRL1) antagonist, inhibits WKYMVm binding to FPRL1 with an IC50 of 0.23 μM. WRW4 specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide[1]. |
|---|---|
| Related Catalog | |
| In Vitro | WRW4 inhibits Abeta42 peptide-induced superoxide generation and chemotactic migration of neutrophils, and also completely inhibits the internalization of Abeta42 peptide in human macrophages. WRW4 specifically blocks ERK phosphorylation downstream of FPRL1 by WKYMVm[1]. |
| References |
| Molecular Formula | C61H65N15O6 |
|---|---|
| Molecular Weight | 1104.27000 |
| Exact Mass | 1103.52000 |
| PSA | 355.46000 |
| LogP | 8.65230 |
| Storage condition | -20℃ |